After quality control, the analyses included 483 BRCA1 (33 breast and 70 prostate cancer cases) and 1318 BRCA2 (244 breast and 141 prostate cancer cases) carriers of European ancestry (Supplementary Tables 1 and 2, available online). This evidence concerns the gene BRCA2 and prostate carcinoma.